Merck will grow its U.S. manufacturing footprint with a $1 billion plant, making it the latest drugmaker to invest in the U.S ...

US President Donald Trump's decision to impose punitive tariffs of 145% for pharmaceutical imports from China,1 effective since April 10, 2025, will pose substantial challenges towards global health ...